No Data
No Data
No Data
No Data
No Data
Taiji Group (600129) 2024 Quarterly Report Review Report: Stable performance in the first quarter, looking forward to sales during the peak season
Event: On April 25, 2024, Taiji Group released its 2024 quarterly report: in the first quarter of 2024, the company achieved operating income of 4.208 billion yuan (-4.96% year-on-year) and net profit of 247 million yuan to mother
國海證券Apr 28 00:00
Taiji Group (600129): The results of the reform have shown that there is still room for improvement in profitability
Guide to this report: The company is an established pharmaceutical company with a full industrial chain layout. Sinopharm has injected new vitality into mixed reform. Profitability has improved markedly in the past two years, and there is still room for improvement in net interest rates; increasing marketing and exploring new attributes of core products is expected to enable high performance growth.
國泰君安Apr 26 16:31
Taiji Group (600129.SH) reported first-quarter results, net profit of 247 million yuan, up 5.05% year-on-year
Taiji Group (600129.SH) released its report for the first quarter of 2024. The company achieved operating income during the reporting period...
Zhitong FinanceApr 25 19:12
These 4 Measures Indicate That Chongqing Taiji Industry(Group)Ltd (SHSE:600129) Is Using Debt Reasonably Well
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved whe
Simply Wall StApr 24 12:23
Express News | Fangzheng Securities: Branded OTC products+brand+channels have an obvious leading effect
BreakingsApr 23 08:44
Taiji Group: Tetrafluorouracil injection passed generic drug consistency evaluation
Taiji Group announced that the terafluorouracil injection passed the generic drug consistency evaluation.
Zhitong FinanceApr 19 15:36
No Data
No Data